AcquisitionOther
Landos Biopharma, Inc. acquired Landos Biopharma, Inc
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Landos Biopharma, Inc. -> Landos Biopharma, Inc · $20.42
The addition of NX-13 complements our portfolio in immunology and strengthens our collective efforts to transform standard of care.
Open source record (SEC) ↗